Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: transfer from osh for further evaluation of pancreas major surgical or invasive procedure: central line placement history of present illness: 70yo female, htn, dm, admitted 3 weeks ago with pulmonary symptoms incl. effusions, ct scan of her lungs also revealed inflammation of pancreas in the upper abdomen (mild stranding), with normal amylase/lipase; no stones, no biliary dilation. did well; went home and then returned with upper abdominal pain and shortness of breath req intubation (acute hypoxia) for 24 hours. extubated and did well so transferred to floor. repeat ct scan now showing diffusely enlarged pancreas with pressure on duodenum and antrum of stomach with ileus; no elevation amylase/lipase, normal biliary ducts. ca -9 normal. kept npo, started on tpn. no nauseau, vomitting. not tender. returned to unit for repeat hypoxia last weekend, believed from infiltrates and effusion, required bipap. now back to nasal cannula--placed on antibiotics and improved. repeat ct scan 2 days ago, worsening peripancreatic inflammation and beginning pseudocyst or cyst/malig. able to advance diet to clears and tolerating. past medical history: asthma dm ii hyperlipidemia htn social history: nonsmoker, nondrinker, no h/o ivdu family history: nc physical exam: vs: t 96 / 130/60 / 77 / 18 / 94% 4l gen: pleasant, a&ox3, not in acute distress heent: no jvd, no lad, op clear, mmm, eom intact, anicteric sclerae lungs: inspiratory wheezes bl, no rales/rhonchi heart: rrr no mrg abd: normoactive, obese, soft tender in ruq, epigastric regions extr: warm, 2+ pt pulses symmetric bl,no cce neuro: cn ii- xii in tact, upper and lower extremity strength, sensation grossly intact skin: no rash, warm and dry pertinent results: 141 98 28 -------------< 167 4.0 32 0.7 ca: 8.5 mg: 2.2 p: 3.6 alt: 17 ap: 99 tbili: 0.3 alb: 2.5 ast: 18 ldh: dbili: tprot: : 42 lip: 22 19.1 > 8.8 < 271 25.3 pt: 13.7 ptt: 29.6 inr: 1.2 cxr : cardiomediastinal contour is unremarkable. aside from a discoid atelectasis in the left lower lobe, the lungs are grossly clear. increased density in the left cp angle laterally is most likely consistent with pleural thickening. there is no pneumothorax. left subclavian vein catheter terminates in the mid svc. cta : 1. no evidence of acute pulmonary embolism or aortic dissection. no evidence of extrinsic airway compression. ct trachea study may be ordered for better assement of airway pathology. 2. questionable small amount of fluid within the distal trachea and right mainstem bronchus likely place patient at risk for aspiration. a more focal area of consolidation is noted along the right minor fissure which appears slightly retracted superiorly. 3. bilateral small pleural effusions and subsegmental atelectasis with a more significant atelectasis noted within the left lower lobe posterior basal segment. 4. intra-abdominal ascites. 5. coronary and aortic vascular calcifications. brief hospital course: 70 yo female with h/o asthma presented to osh with asthma flare found to have new pancreatic transferred to for further w/u. . # asthma flare: she has h/o asthma which had been inactive for several years until recently she had 3 hospitalization within the past few months for asthma flare. twice she was intubated including this recent hospitalization at osh before transfer to on . pfts from osh demonstrated clear obstructive picture. on transfer here, her respiratory status was improving and she was kept on nebs and finished a course of antibiotics while her steroids were weaned off. then she decompesated on with tachypnea and increased work of breathing. she was admitted to the micu for closer observation and required brief period of bipap. cta was negative for pe and there was questionable pneumonia. she was put on steroids again and was started on a course of levofloxacin. she was transferred back on the regular medicine service on when he respiratory status stabilized once again and was followed by pulmonary consult team. she was on room air on discharge, and she should continue standing xopenex/ipratroprium nebs. she should also continue montelukast, advair and a long steroid taper starting with prednisone 40mg daily x 1 week and tapering by 5mg each week. she recieved 6 days of levofloxacin and pulmonary consult agreed with stopping abx. . of note, sputum culture grew out mrsa on but this was felt to be from colonization since she currently does not have signs and symptoms of pna: afebrile and stable on room air without cough or sputum. . apparently, rast at osh was positive for dust mites. her anca was negative. bedside evaluation from speech and swallow did not demonstrate aspiration. . she has followup at pulmonary clinic on for management of her chronic asthma. . # pancreas: during workup for her asthma flare at osh, her pancreas was imaged for unclear reasons. the ct report reads: "extensive cystic change throughout the pancreas and peripancreatic soft tissue. this is most suggestive of pancreatic pseudocyst formation with associated phlegmonous tisse and presumed acute pancreatitis. a cystic neoplasm, however, cannot be excluded and would be reason within the different diagnosis. the cystic formation is somewhat more extensive than previously seen." there was no elevated in amylase and lipase and her biliary ducts were normal. ca -9 was normal. she was initially put on bowel rest and tpn per recommendations from the ercp team. later, she was transitioned to a diet and tolerated that without a problem. surgery was consulted and felt that there was no urgent need for surgery at this time. she needs to follow up as an outpatient and has a scheduled appointment with dr. in surgery on . . there was a concern from the pulmonary team that this could be autoimmune pancreatitis because there may be a link to asthma. dr. from gi was consulted and agreed with the possibilty given her asymptomatic presentation of pancreatitis. igg4 levels and cfrt mutation panel were sent and were pending at discharge. she will taper her steroids slowly starting at 40mg daily and tapering down by 5mg each week. she has followup arranged with dr. 0n . . # dm ii: managed with riss and glargine 8 u at bedtime. since she is on steroids, her blood sugars have some variation. she will need outpatient follow up also. . # hyperlipidemia - conitinued po lipitor. . # htn - continued diltiazem. . # anxiety - continued zolpidem and lorazepam. . # code: full . medications on admission: sporanox theophylline lasix colace cardizem ssi tylenol protonix ativan dilaudid levoflox albuterol spiriva lovenox advair prednisone discharge medications: 1. fluticasone-salmeterol 250-50 mcg/dose disk with device sig: one (1) disk with device inhalation (2 times a day). 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day) as needed for constipation. 3. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed. 4. ipratropium bromide 0.02 % solution sig: one (1) inhalation every six (6) hours. 5. insulin glargine 100 unit/ml solution sig: six (6) units subcutaneous at bedtime. 6. insulin regular human 100 unit/ml solution sig: one (1) injection asdir. 7. zolpidem 5 mg tablet sig: one (1) tablet po hs (at bedtime) as needed. 8. atorvastatin 40 mg tablet sig: one (1) tablet po daily (daily). 9. ascorbic acid 500 mg tablet sig: one (1) tablet po bid (2 times a day). 10. zinc sulfate 220 (50) mg capsule sig: one (1) capsule po daily (daily). 11. heparin lock flush (porcine) 100 unit/ml syringe sig: one (1) ml intravenous daily (daily) as needed. 12. protonix 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po once a day. 13. vitamin d 400 unit tablet sig: two (2) tablet po once a day. 14. dilt-xr 120 mg capsule,degradable cnt release sig: one (1) capsule,degradable cnt release po once a day. 15. oxycodone-acetaminophen 5-325 mg tablet sig: one (1) tablet po q4-6h (every 4 to 6 hours) as needed. 16. heparin (porcine) 5,000 unit/ml solution sig: one (1) injection tid (3 times a day). 17. montelukast 10 mg tablet sig: one (1) tablet po daily (daily). 18. levalbuterol hcl 0.63 mg/3 ml solution sig: one (1) ml inhalation every six (6) hours. 19. insulin glargine 100 unit/ml solution sig: eight (8) subcutaneous at bedtime: also cover patient with regular insulin sliding scale. 20. prednisone 20 mg tablet sig: two (2) tablet po daily (daily): taper: 40mg x 1 week, first day . 35mg x 1 week 30mg x 1 week 25mg x 1 week 20mg x 1 week 15mg x 1 week 10mg x 1 week 5mg x 1 week off. discharge disposition: extended care facility: - discharge diagnosis: primary: 1. idiopathic pancreatitis - pseudocyst. 2. acute exacerbation of copd. 3. deconditioning - immobility. 4. malnutrition. secondary: 1. obesity. 2. diabetes mellitus type ii. 3. hypertension. 4. hyperlipidemia. discharge condition: hemodynamically stable, afebrile discharge instructions: please take all medications as prescribed if you have chest pain, shortness of breath, palpitations, nausea, vomitting, diarrhea please call the doctor on call or go to the emergency room. followup instructions: please make a follow up appointment with your primary care doctor () within 2 weeks of discharge please follow up with surgery clinic about your pancreas. this is an important appointment to keep: provider: , md phone: date/time: 8:30 follow up with dr. at clinic for further evaluation for your pancreas: provider: , md phone: date/time: 9:20 procedure: venous catheterization, not elsewhere classified parenteral infusion of concentrated nutritional substances diagnoses: anemia, unspecified unspecified pleural effusion unspecified essential hypertension unspecified protein-calorie malnutrition other and unspecified hyperlipidemia anxiety state, unspecified pressure ulcer, lower back diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled obesity, unspecified chronic obstructive asthma with (acute) exacerbation acute pancreatitis cyst and pseudocyst of pancreas 

Answer: The patient is high likely exposed to